2016 - CİLT 26 SAYI: 2

Hizli-Sayar G, Cetin M.
Psychobiotics: the potential therapeutic promise of microbes in psychiatry
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):93-102
doi:10.5455/bcp.20160531111208

 
Belenichev IF, Sokolik EP, Bukhtiarova NV, Levich SV.
Pharmacological modulation of Heat Shock Protein 70 (HSP70) – dependent mechanisms of endogenous neuroprotection in conditions of prenatal chronic alcoholism by Cerebrocurin and Tiocetam
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):103-8
doi:10.5455/bcp.20151003061901

 
Umut G, Atagun MI, Evren C, Yilmaz-Cengel H, Hisim O, Keskinkilic C.
The changes of the cognitive and psychomotor functions in the chronic cannabis users after a month of remission
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):109-18
doi:10.5455/bcp.20151019014343

 
Simsek S, Gencoglan S, Ozaner S, Kaplan I, Kaya MC.
Antioxidant status and DNA damage in children with attention deficit hyperactivity disorder with or without comorbid disruptive behavioral disorders
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):119-25
doi:10.5455/bcp.20151003063820

 
Cop E, Oner O, Yurtbasi P, Munir K.
Effects of maternal symptom ratings and other clinical features on short-term treatment response to OROS methylphenidate in children and adolescents with ADHD in a naturalistic clinical setting
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):126-33
doi:10.5455/bcp.20150703013708

 
Aldemir S, Acar M, Ocak Z, Dalbudak E, Yigitoglu MR, Gunduz E.
Association of 5-HT1A and 5-HT1B gene polymorphisms with obsessive-compulsive disorder in a Turkish population
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):134-40
doi:10.5455/bcp.20151003063454

 
Bolek S, Yargic I, Ekinci O.
The effects of Buprenorphine/Naloxane maintenance treatment on the quality of life, substance use and functionality in opiate dependence: a follow-up study
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):141-51
doi:10.5455/bcp.20151101022909

 
Deniz S, Sancar M, Okuyan B, Ata P, Bingol-Ozakpinar O, Talas A, Gunes T, Caliskan M, Izzettin FV.
Determination of CYP2C19 polymorphism, side effects, and medication adherence in patients who have utilized selective serotonin reuptake inhibitors
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):152-60
doi:10.5455/bcp.20151003060610

 
Semiz M, Solmaz V, Aksoy D, Inanir S, Colak B, Gokbakan MA, Inanir A.
Prevalence of restless legs syndrome among psychiatric patients who are under antidepressant or antipsychotic monotherapy
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):161-8
doi:10.5455/bcp.20150908024954

 
Akpinar A, Yaman AR, Karakus K, Atay IM, Demirci K.
The frequency of benzodiazepine use in the Isparta Province
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):169-74
doi:10.5455/bcp.20150707103818

 
Soysal P, Isik AT, Usarel C, Kaya D, Ellidokuz H, Grossberg GT.
Validity and reliability of “AM SAD”, a short geriatric depression screening tool, in Turkish elderly people
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):175-80
doi:10.5455/bcp.20150910032337

 
Taskiran S, Tufan AE, Semerci B.
Aripiprazole can a viable choice for persistant suppression of symptoms in managing chronic tic disorders and Tourette’s disorder through the life span: a case series
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):181-5
doi:10.5455/bcp.20160220032354

Es H, Esen-Melez I, Ozgun A, Melez DO, Kertmen C, Cavlak M.
Sudden death associated with hypersensitivity myocarditis induced by clozapine: An autopsy case
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):186-90
doi:10.5455/bcp.20151216022322

 
Li Z, Xiong Z, Liu X, Tang X, Li T.
Missing the diagnosis in a young woman with repeated hospital admissions: a case report
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):191-5
doi:10.5455/bcp.20160105112215

 
Sahin C, Dursun S, Cetin M, Aricioglu F.
The neuroinflammation perspective of depression: reuniting the outstanding mechanisms of the pathophysiology
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):196-206
doi:10.5455/bcp.20160520092044

 
Gulec MA, Akyol O, Akyol S.
Propolis as a complex compound may contain many active ingredients like caffeic acid phenethyl ester (CAPE)
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):207-8
doi:10.5455/bcp.20151006014845

 
Baskoy K, Ay SA, Deniz F, Yonem A.
Massive creatine kinase elevation during antipsychotic drug treatment with olanzapine and quetiapine
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):210-1
doi:10.5455/bcp.20151209125410

 
Ozturk Z.
Faces and shadows: cabergoline-induced acute psychosis in a woman with no previous psychiatric history
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):211-2
doi:10.5455/bcp.20151203010237

 
Surer-Adanir A.
Priapism associated with aripiprazole and quetiapine in an 8-year-old boy with autism
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):212-3
doi:10.5455/bcp.20151221101229

 
Eray S, Ucar HN, Vural AP.
Sertraline-induced diplopia
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):213-4
doi:10.5455/bcp.20160109124021